Skip to main content

Table 4 Follow-up of 21 patients assessed for chest pain with an initial hs-cTnT level of ≥15 ng/L but no signs of AMI or UA

From: Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study

 

hs-cTnT ≥15 ng/L without AMI or UA n = 21

hs-cTnT after 2–3 years

P value

<15 ng/L n = 7

≥15 ng/L n = 14

Age (years)

81 ± 9

75 ± 9

83 ± 7

0.049

Male

16 (76)

5 (71)

11 (79)

1.000

Risk factors

 Current smokers

0

0

0

 

 Diabetes

6 (29)

2 (29)

4 (29)

1.000

 Hypertension

18 (86)

5 (71)

13 (93)

0.247

 Hypercholesterolaemia

7 (33)

3 (43)

4 (29)

0.638

Cardiovascular disease

 Angina pectoris

1 (5)

1 (14)

0

0.333

 Previous AMI

3 (14)

2 (29)

1 (7)

0.247

 Heart failure

3 (14)

1(14)

2 (14)

1.000

 Aortic valve disease

3 (14)

1 (14)

2 (14)

1.000

ECG findings

 Atrial fibrillation

8 (38)

2 (29)

6 (43)

0.656

Laboratory findings

    

 eGFR (mL/min)

62 ± 17

74 ± 11

56 ± 16

0.017

 NT-proBNP (ng/L)a

440 ± 775

150 ± 338

1,245 ± 883

0.017

 Cholesterol (mmol/L)

4.5 ± 1.3

4.4 ± 1.7

4.6 ± 1.2

0.754

Symptoms and findings

 Angina pectoris or dyspnoea

3 (14)

2 (29)

1 (7)

0.247

 Length (cm)

173 ± 7

173 ± 10

173 ± 7

0.847

 Body weight (kg)

85 ± 13

85 ± 10

84 ± 15

0.889

 BMI (kg/m2)

28 ± 4

29 ± 5

28 ± 4

0.862

 Waist circumference (cm)

106 ± 11

107 ± 11

106 ± 11

0.878

 Systolic BP (mm Hg)a

120 ± 10

120 ± 2.5

130 ± 11

0.176

 Diastolic BP (mm Hg)a

70 ± 6

70 ± 7

65 ± 6

0.658

  1. Patients are divided into groups according to hs-cTnT level 2–3 years after the initial assessment.
  2. Values are presented as mean ± SD or number (%) as appropriate.
  3. aMedian ± quartile deviation.